10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
PFIZER INC | ||
Ticker: PFE Fiscal Year: 2021 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2021 10-K (Filed: Feb 24, 2022) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2021 | Dec 31, 2020 | |
| Assets | ||
| Cash and cash equivalents | $ 1,944 | 1,786 |
| Short-term investments | 29,125 | 10,437 |
| Trade accounts receivable, less allowance for doubtful accounts: 2021$492; 2020$508 | 11,479 | 7,913 |
| Inventories | 9,059 | 8,020 |
| Current tax assets | 4,266 | 3,264 |
| Other current assets | 3,820 | 3,646 |
| Total current assets | 59,693 | 35,067 |
| Equity-method investments | 16,472 | 16,856 |
| Long-term investments | 5,054 | 3,406 |
| Property, plant and equipment | 14,882 | 13,745 |
| Identifiable intangible assets | 25,146 | 28,337 |
| Goodwill | 49,208 | 49,556 |
| Noncurrent deferred tax assets and other noncurrent tax assets | 3,341 | 2,383 |
| Other noncurrent assets | 7,679 | 4,879 |
| Total assets | 181,476 | 154,229 |
| Liabilities and Equity | ||
| Short-term borrowings, including current portion of long-term debt: 2021$1,636; 2020$2,002 | 2,241 | 2,703 |
| Trade accounts payable | 5,578 | 4,283 |
| Dividends payable | 2,249 | 2,162 |
| Income taxes payable | 1,266 | 1,049 |
| Accrued compensation and related items | 3,332 | 3,049 |
| Deferred revenues | 3,067 | 1,113 |
| Other current liabilities | 24,939 | 11,561 |
| Total current liabilities | 42,671 | 25,920 |
| Long-term debt | 36,195 | 37,133 |
| Pension benefit obligations | 3,489 | 4,766 |
| Postretirement benefit obligations | 235 | 645 |
| Noncurrent deferred tax liabilities | 349 | 4,063 |
| Other taxes payable | 11,331 | 11,560 |
| Other noncurrent liabilities | 9,743 | 6,669 |
| Total liabilities | 104,013 | 90,756 |
| Commitments and Contingencies | ||
| Preferred stock, no par value, at stated value; 27 shares authorized; no shares issued or outstanding at December 31, 2021 and December 31, 2020 | 0 | 0 |
| Common stock, $0.05 par value; 12,000 shares authorized; issued: 20219,471; 20209,407 | 473 | 470 |
| Additional paid-in capital | 90,591 | 88,674 |
| Treasury stock, shares at cost: 20213,851; 20203,840 | (111,361) | (110,988) |
| Retained earnings | 103,394 | 90,392 |
| Accumulated other comprehensive loss | (5,897) | (5,310) |
| Total Pfizer Inc. shareholders equity | 77,201 | 63,238 |
| Equity attributable to noncontrolling interests | 262 | 235 |
| Total equity | 77,462 | 63,473 |
| Total liabilities and equity | 181,476 | 154,229 |
| External Links | |
| PFIZER INC (PFE) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |